Replimune (REPL) EPS (Basic) (2017 - 2026)

Replimune (REPL) reported EPS (Basic) of -$0.79 for Q1 2026, up 14.26% on a YoY basis from -$0.69 in Q1 2025, and down 2.54% sequentially from -$0.77 in Q4 2025.

Replimune (REPL) EPS (Basic) (2017 - 2026) Analysis & Trends

Replimune (REPL) has 10 years of EPS (Basic) data on file, last reported at -$0.79 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 14.26% year-over-year to -$0.79; the trailing twelve-month figure through Mar 2026 stood at -$3.38 (down 10.21% YoY), and the FY2026 full-year result was -$3.38, down 10.21% from the prior year.
  • EPS (Basic) declined to -$0.79 in Q1 2026, from -$0.77 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.61 in Q1 2022 to a low of -$0.95 in Q2 2025.
  • A 5-year average of -$0.8 and a median of -$0.79 in 2022 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) slumped 48.14% in 2022 and climbed 25.12% in 2024, its largest moves.
  • Tracing REPL's EPS (Basic) over 5 years: stood at -$0.69 in 2022, then decreased by 11.81% to -$0.77 in 2023, then retreated by 3.58% to -$0.79 in 2024, then increased by 3.16% to -$0.77 in 2025, then decreased by 2.54% to -$0.79 in 2026.
  • Business Quant data shows REPL's EPS (Basic) at -$0.79 in Q1 2026, -$0.77 in Q4 2025, and -$0.9 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Replimune 970.73 Mn 970.73 Mn - -0.79

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.79
Dec 31, 2025 -0.77
Sep 30, 2025 -0.90
Jun 30, 2025 -0.95
Mar 31, 2025 -0.92
Dec 31, 2024 -0.79
Sep 30, 2024 -0.68
Jun 30, 2024 -0.78
Mar 31, 2024 -0.83
Dec 31, 2023 -0.77
Sep 30, 2023 -0.90
Jun 30, 2023 -0.75
Mar 31, 2023 -0.85
Dec 31, 2022 -0.69
Sep 30, 2022 -0.79
Jun 30, 2022 -0.78
Mar 31, 2022 -0.61
Dec 31, 2021 -0.57
Sep 30, 2021 -0.56
Jun 30, 2021 -0.53